Join the global vascular and endovascular community

Charing Cross (CX) Symposium 2027 returns for its 49th year on 6 – 8 April 2027 at Olympia, London. Come and join us as we welcome the largest international community of clinicians, educators, innovators and industry partners in vascular disease management.

Across three days, CX Symposium will feature a physician-led scientific programme built around lively debate, peer-to-peer exchange, and an audience as expert as those presenting. With 500+ presentations, 300+ discussions, hands-on workshops, podium-first data, live and edited cases and an exhibition, CX Symposium brings together international speakers and the future leaders of vascular care to interrogate the evolving evidence base and its practical implications for best patient outcomes.

Registration opens soon.

CX Co-Chairs

Dittmar Böckler
Dittmar BöcklerHeidelberg, Germany
Andrew Holden
Andrew HoldenAuckland, New Zealand
Erin Murphy
Erin MurphyCharlotte, United States

2026 On-Demand

CX Symposium News

FAQs

Latest CX news

CX Vascular Access Skills Course among “the best in Europe”

April 28th, 2017|Comments Off on CX Vascular Access Skills Course among “the best in Europe”

Described as “one of the best” courses of its kind in Europe, this year’s CX Vascular Access Skills course took delegates through each stage of the patient journey, from diagnosis, to treatment, to complication [...]

CX salutes Edward B Diethrich – an endovascular pioneer

April 28th, 2017|Comments Off on CX salutes Edward B Diethrich – an endovascular pioneer

There was a special session convened yesterday at CX to appreciate and recognise Edward B Diethrich’s life, untrammelled spirit, masterful surgical competence, and enormous influence in the cardiovascular field. The internationally esteemed cardiovascular surgeon, [...]

Call for an advance in the treatment of aortic dissections at CX

April 28th, 2017|Comments Off on Call for an advance in the treatment of aortic dissections at CX

Experts in the Thoracic Aortic Plenary sessions yesterday discussed cutting-edge topics that lack support from strong data, making consensus difficult to achieve. Many unanswered questions were raised such as which patients with thoracic disease [...]